Literature DB >> 20659789

Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data.

Peilin Jia1, Lily Wang, Herbert Y Meltzer, Zhongming Zhao.   

Abstract

Unlike the typical analysis of single markers in genome-wide association studies (GWAS), we incorporated Gene Set Enrichment Analysis (GSEA) and hypergeometric test and combined them using Fisher's combined method to perform pathway-based analysis in order to detect genes' combined effects on mediating schizophrenia. A few pathways were consistently found to be top ranked and likely associated with schizophrenia by these methods; they are related to metabolism of glutamate, the process of apoptosis, inflammation, and immune system (e.g., glutamate metabolism pathway, TGF-beta signaling pathway, and TNFR1 pathway). The genes involved in these pathways had not been detected by single marker analysis, suggesting this approach may complement the original analysis of GWAS dataset. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659789      PMCID: PMC2933424          DOI: 10.1016/j.schres.2010.07.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

1.  New models of collaboration in genome-wide association studies: the Genetic Association Information Network.

Authors:  Teri A Manolio; Laura Lyman Rodriguez; Lisa Brooks; Gonçalo Abecasis; Dennis Ballinger; Mark Daly; Peter Donnelly; Stephen V Faraone; Kelly Frazer; Stacey Gabriel; Pablo Gejman; Alan Guttmacher; Emily L Harris; Thomas Insel; John R Kelsoe; Eric Lander; Norma McCowin; Matthew D Mailman; Elizabeth Nabel; James Ostell; Elizabeth Pugh; Stephen Sherry; Patrick F Sullivan; John F Thompson; James Warram; David Wholley; Patrice M Milos; Francis S Collins
Journal:  Nat Genet       Date:  2007-09       Impact factor: 38.330

2.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder.

Authors:  Peter Holmans; Elaine K Green; Jaspreet Singh Pahwa; Manuel A R Ferreira; Shaun M Purcell; Pamela Sklar; Michael J Owen; Michael C O'Donovan; Nick Craddock
Journal:  Am J Hum Genet       Date:  2009-06-18       Impact factor: 11.025

3.  Control of synaptic strength by glial TNFalpha.

Authors:  Eric C Beattie; David Stellwagen; Wade Morishita; Jacqueline C Bresnahan; Byeong Keun Ha; Mark Von Zastrow; Michael S Beattie; Robert C Malenka
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

Review 4.  Transforming growth factor-beta signalling in brain disorders.

Authors:  Denis Vivien; Carine Ali
Journal:  Cytokine Growth Factor Rev       Date:  2005-11-03       Impact factor: 7.638

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.

Authors:  C O'Dushlaine; E Kenny; E Heron; G Donohoe; M Gill; D Morris; A Corvin
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

7.  A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case.

Authors:  Jingchun Sun; Peilin Jia; Ayman H Fanous; Bradley T Webb; Edwin J C G van den Oord; Xiangning Chen; Jozsef Bukszar; Kenneth S Kendler; Zhongming Zhao
Journal:  Bioinformatics       Date:  2009-07-14       Impact factor: 6.937

8.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

9.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

10.  Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence.

Authors:  René Gysin; Rudolf Kraftsik; Julie Sandell; Pierre Bovet; Céline Chappuis; Philippe Conus; Patricia Deppen; Martin Preisig; Viviane Ruiz; Pascal Steullet; Mirjana Tosic; Thomas Werge; Michel Cuénod; Kim Q Do
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

View more
  93 in total

1.  dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks.

Authors:  Peilin Jia; Siyuan Zheng; Jirong Long; Wei Zheng; Zhongming Zhao
Journal:  Bioinformatics       Date:  2010-11-02       Impact factor: 6.937

2.  DNA methylation signatures in development and aging of the human prefrontal cortex.

Authors:  Shusuke Numata; Tianzhang Ye; Thomas M Hyde; Xavier Guitart-Navarro; Ran Tao; Michael Wininger; Carlo Colantuoni; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

Review 3.  Network.assisted analysis to prioritize GWAS results: principles, methods and perspectives.

Authors:  Peilin Jia; Zhongming Zhao
Journal:  Hum Genet       Date:  2014-02       Impact factor: 4.132

Review 4.  Inhibitory neurons in human cortical circuits: substrate for cognitive dysfunction in schizophrenia.

Authors:  David A Lewis
Journal:  Curr Opin Neurobiol       Date:  2013-11-30       Impact factor: 6.627

5.  Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.

Authors:  Benneth Ben-Azu; Adegbuyi Oladele Aderibigbe; Aya-Ebi Okubo Eneni; Abayomi Mayowa Ajayi; Solomon Umukoro; Ezekiel O Iwalewa
Journal:  Neurochem Res       Date:  2018-06-28       Impact factor: 3.996

Review 6.  The Emerging Immunogenetic Architecture of Schizophrenia.

Authors:  Jennie G Pouget
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

7.  Elevated viral restriction factor levels in cortical blood vessels in schizophrenia.

Authors:  Benjamin I Siegel; Elizabeth J Sengupta; Jessica R Edelson; David A Lewis; David W Volk
Journal:  Biol Psychiatry       Date:  2013-09-30       Impact factor: 13.382

8.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

9.  Integration of Enhancer-Promoter Interactions with GWAS Summary Results Identifies Novel Schizophrenia-Associated Genes and Pathways.

Authors:  Chong Wu; Wei Pan
Journal:  Genetics       Date:  2018-05-04       Impact factor: 4.562

10.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.